Retraction of: Conventional steroids vs. dual-release hydrocortisone on metabolic, cardiovascular, and bone outcomes in adrenal insufficiency: a 10-year study
- PMID: 40105202
- DOI: 10.1093/ejendo/lvaf049
Retraction of: Conventional steroids vs. dual-release hydrocortisone on metabolic, cardiovascular, and bone outcomes in adrenal insufficiency: a 10-year study
Retraction of
-
Conventional steroids vs. dual-release hydrocortisone on metabolic, cardiovascular, and bone outcomes in adrenal insufficiency: a 10-year study.Eur J Endocrinol. 2024 Aug 30;191(3):300-311. doi: 10.1093/ejendo/lvae107. Eur J Endocrinol. 2024. Retraction in: Eur J Endocrinol. 2025 Mar 3;192(3):Z1. doi: 10.1093/ejendo/lvaf049. PMID: 39171906 Retracted. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources